These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 27085900)
1. Dopamine dynamics during emotional cognitive processing: Implications of the specific actions of clozapine compared with haloperidol. Kawano M; Oshibuchi H; Kawano T; Muraoka H; Tsutsumi T; Yamada M; Inada K; Ishigooka J Eur J Pharmacol; 2016 Jun; 781():148-56. PubMed ID: 27085900 [TBL] [Abstract][Full Text] [Related]
2. Aripiprazole and haloperidol suppress excessive dopamine release in the amygdala in response to conditioned fear stress, but show contrasting effects on basal dopamine release in methamphetamine-sensitized rats. Oshibuchi H; Inada K; Sugawara H; Ishigooka J Eur J Pharmacol; 2009 Aug; 615(1-3):83-90. PubMed ID: 19477171 [TBL] [Abstract][Full Text] [Related]
3. Valproic acid inhibits excess dopamine release in response to a fear-conditioned stimulus in the basolateral complex of the amygdala of methamphetamine-sensitized rats. Miyagi J; Oshibuchi H; Kasai A; Inada K; Ishigooka J Eur J Pharmacol; 2014 May; 730():20-5. PubMed ID: 24583338 [TBL] [Abstract][Full Text] [Related]
4. Escitalopram attenuates fear stress-induced increase in amygdalar dopamine following methamphetamine-induced sensitisation: Implications of fine-tuning action of selective serotonin reuptake inhibitors on emotional processing. Muraoka H; Oshibuchi H; Kawano M; Kawano T; Tsutsumi T; Yamada M; Ishigooka J; Nishimura K; Inada K Eur J Pharmacol; 2018 Sep; 834():1-9. PubMed ID: 29981749 [TBL] [Abstract][Full Text] [Related]
5. [Significance of the pharmacotherapy of schizophrenia in the emotional context processing of cognition]. Inada K; Oshibuchi H; Shigooka J Nihon Shinkei Seishin Yakurigaku Zasshi; 2013 Jun; 33(3):101-4. PubMed ID: 25069242 [TBL] [Abstract][Full Text] [Related]
6. [Action of amygdala dopamine and effect of antipsychotics]. Oshibuchi H; Inada K; Ishigooka J Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Apr; 30(2):93-9. PubMed ID: 20491283 [TBL] [Abstract][Full Text] [Related]
7. Diazepam suppresses the stress-induced dopaminergic release in the amygdala of methamphetamine-sensitized rat. Kawano T; Oshibuchi H; Kawano M; Muraoka H; Tsutsumi T; Yamada M; Ishigooka J; Nishimura K; Inada K Eur J Pharmacol; 2018 Aug; 833():247-254. PubMed ID: 29885289 [TBL] [Abstract][Full Text] [Related]
8. The muscarinic receptor agonist xanomeline has an antipsychotic-like profile in the rat. Stanhope KJ; Mirza NR; Bickerdike MJ; Bright JL; Harrington NR; Hesselink MB; Kennett GA; Lightowler S; Sheardown MJ; Syed R; Upton RL; Wadsworth G; Weiss SM; Wyatt A J Pharmacol Exp Ther; 2001 Nov; 299(2):782-92. PubMed ID: 11602695 [TBL] [Abstract][Full Text] [Related]
9. Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex. Gessa GL; Devoto P; Diana M; Flore G; Melis M; Pistis M Neuropsychopharmacology; 2000 Jun; 22(6):642-9. PubMed ID: 10788763 [TBL] [Abstract][Full Text] [Related]
10. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol. Gaisler-Salomon I; Weiner I Psychopharmacology (Berl); 2003 Apr; 166(4):333-42. PubMed ID: 12599023 [TBL] [Abstract][Full Text] [Related]
11. Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations. Yamamoto BK; Cooperman MA J Neurosci; 1994 Jul; 14(7):4159-66. PubMed ID: 7913120 [TBL] [Abstract][Full Text] [Related]
12. Tyrosine augments acute clozapine- but not haloperidol-induced dopamine release in the medial prefrontal cortex of the rat: an in vivo microdialysis study. Jaskiw GE; Collins KA; Pehek EA; Yamamoto BK Neuropsychopharmacology; 2001 Jul; 25(1):149-56. PubMed ID: 11377928 [TBL] [Abstract][Full Text] [Related]
13. Clozapine-induced dopamine release in the medial prefrontal cortex is augmented by a moderate concentration of locally administered tyrosine but attenuated by high tyrosine concentrations or by tyrosine depletion. Jaskiw GE; Kirkbride B; Newbould E; Young D; Durkalski V; Bongiovanni R Psychopharmacology (Berl); 2005 Jun; 179(4):713-24. PubMed ID: 15682305 [TBL] [Abstract][Full Text] [Related]
14. Haloperidol- and clozapine-induced enhancement of latent inhibition with extended conditioning: implications for the mechanism of action of neuroleptic drugs. Weiner I; Shadach E; Barkai R; Feldon J Neuropsychopharmacology; 1997 Jan; 16(1):42-50. PubMed ID: 8981387 [TBL] [Abstract][Full Text] [Related]
15. Amisulpride the 'atypical' atypical antipsychotic--comparison to haloperidol, risperidone and clozapine. Natesan S; Reckless GE; Barlow KB; Nobrega JN; Kapur S Schizophr Res; 2008 Oct; 105(1-3):224-35. PubMed ID: 18710798 [TBL] [Abstract][Full Text] [Related]
16. Dopamine D1 receptor-dependent regulation of extracellular citrulline level in the rat nucleus accumbens during conditioned fear response. Saulskaya NB; Fofonova NV; Sudorghina PV; Saveliev SA Neurosci Lett; 2008 Aug; 440(2):185-9. PubMed ID: 18555608 [TBL] [Abstract][Full Text] [Related]
17. Clozapine but not haloperidol treatment reverses sub-chronic phencyclidine-induced disruption of conditional discrimination performance. Dunn MJ; Killcross S Behav Brain Res; 2006 Dec; 175(2):271-7. PubMed ID: 17027093 [TBL] [Abstract][Full Text] [Related]
18. A drug-drug conditioning paradigm reveals multiple antipsychotic-nicotine interactions. Feng M; Sparkman NL; Sui N; Li M J Psychopharmacol; 2017 Apr; 31(4):474-486. PubMed ID: 28347260 [TBL] [Abstract][Full Text] [Related]
19. Dopamine and serotonin metabolism in response to chronic administration of fluvoxamine and haloperidol combined treatment. Chertkow Y; Weinreb O; Youdim MB; Silver H J Neural Transm (Vienna); 2007; 114(11):1443-54. PubMed ID: 17576515 [TBL] [Abstract][Full Text] [Related]
20. Clozapine and olanzapine exhibit an intrinsic anxiolytic property in two conditioned fear paradigms: contrast with haloperidol and chlordiazepoxide. Mead A; Li M; Kapur S Pharmacol Biochem Behav; 2008 Oct; 90(4):551-62. PubMed ID: 18547622 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]